Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep-Oct;12(5):633-638.
doi: 10.1016/j.jobcr.2022.08.013. Epub 2022 Aug 17.

Evaluation of serum and salivary PCSK9 and IL6 and its association with periodontal inflammation and atherosclerotic cardiovascular diseases

Affiliations

Evaluation of serum and salivary PCSK9 and IL6 and its association with periodontal inflammation and atherosclerotic cardiovascular diseases

Roshan R Rughwani et al. J Oral Biol Craniofac Res. 2022 Sep-Oct.

Erratum in

Abstract

Background: and Purpose: The aim of this study was to assess, compare and correlate the ability of PCSK9 and IL6 as potential common serum and salivary biomarkers for stage III/IV periodontitis and the risk of developing atherosclerotic cardiovascular diseases.

Methods: 76 patients were alloted into 4 groups consisting of subjects with clinically healthy periodontium and stage III/IV periodontitis with and without ACVD. Clinical parameters - PD, CAL, number of teeth, PI, mSBI, TC, Tg, HDL and LDL were recorded. Serum and saliva samples were obtained and subjected to ELISA for quantifying the biomarker levels.

Results: The level of these biomarkers was found to be the lowest (IL6 Serum: 21.92 ± 14.54, IL6 Saliva: 12.34 ± 7.72, PCSK9 Serum: 178.82 ± 35.07, PCSK9 Saliva: 80.82 ± 25.43) in group I and highest in group IV (IL6 Serum: 73.4 ± 24.86, IL6 Saliva: 37.66 ± 15.77, PCSK9 Serum: 346.54 ± 45.11, PCSK9 Saliva: 157.72 ± 43.28). The clinical parameters PI, mSBI, PPD, CAL, total number of teeth, TC, HDL and LDL showed a significant correlation with biomarkers PCSK9 and IL6.

Conclusion: This study features the elevation of serum and salivary PCSK9 and IL6 in periodontitis and ACVD. A triad of serum and salivary PCSK9 and IL6 along with the clinical markers of periodontal disease can relatively predict the future risk of developing ACVD.

Keywords: Atherosclerotic cardiovascular disease; Biomarkers; Chronic inflammation; IL6; PCSK9; Periodontal disease.

PubMed Disclaimer

Figures

Image 1
Graphical abstract
Fig. 1
Fig. 1
Scatter plot representing correlation between biomarkers in all groups.
Fig. 2
Fig. 2
ROC demonstrating the performance of the biomarkers.

References

    1. Balaji S., Cholan P.K., Victor D.J. Evaluation of “soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), interleukin-1β, and matrix metalloproteinase-8” as a short panel of salivary biomarkers in patients with and without stage III/IV periodontitis and type 2 diabetes mellitus. J Oral Biol Craniofacial Res. 2022;12(1):33–37. doi: 10.1016/j.jobcr.2021.10.003. [Internet] Available from: - DOI - PMC - PubMed
    1. Pahwa R., Jialal I. Atherosclerosis. 2022. Treasure Island (FL)
    1. Lavigne S.E., Forrest J.L. An umbrella review of systematic reviews examining the relationship between type 2 diabetes and periodontitis: position paper from the Canadian Dental Hygienists Association. Can J Dent Hyg. 2021;55(1):57–67. - PMC - PubMed
    1. Momtazi-Borojeni A.A., Sabouri-Rad S., Gotto A.M., et al. PCSK9 and inflammation: a review of experimental and clinical evidence. Eur Hear J - Cardiovasc Pharmacother. 2019;5(4):237–245. - PubMed
    1. Ricci C., Ruscica M., Camera M., et al. PCSK9 induces a pro-inflammatory response in macrophages. Sci Rep [Internet] 2018;8(1):1–10. doi: 10.1038/s41598-018-20425-x. Available from: - DOI - PMC - PubMed

LinkOut - more resources